The statement that is true about cystic fibrosis is:
Carriers have an advantage over people who do not have the cystic fibrosis mutation.
This statement refers to the "heterozygote advantage," where carriers (those with one copy of the cystic fibrosis allele and one normal allele) may have some increased resistance to certain diseases, such as tuberculosis.
The other statements are incorrect:
- Cystic fibrosis is caused by a mutation in the CFTR gene, which is a recessive disorder, not a dominant-recessive replacement.
- The mutation that typically leads to cystic fibrosis is a deletion of three nucleotides (not one codon), resulting in the loss of the amino acid phenylalanine in the CFTR protein.
- Cystic fibrosis primarily affects the respiratory and digestive systems, not the ability to make normal red blood cells.